Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients, Integrating the Complete Care Pathway and an Interoperable Clinical Interface With Algorithms Paired With Explainability Tools.

NCT07546188 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.

NCT NCT07546188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients, Integrating the Complete Care Pathway and an Interoperable Clinical Interface With Algorithms Paired With Explainability Tools.
Lead sponsor
Grand Hôpital de Charleroi
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2026
Completion date
February 15, 2029
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

care coordination, lymphoma, non-hodgkin